RMD FINANCIAL STATEMENTS

Resmed Inc — balance sheet, income statement and cash flow trends

RMDResmed Inc

🇦🇺 Australia · AU · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue5.5 B $+10.5%

Gross Profit3.4 B $+15.5%

Operating Income1.9 B $+18.5%

EBITDA2.2 B $+19.7%

Net Income1.5 B $+15.9%

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
RMD	10.5%	61.2%	39.1%	27.4%
WST	11.2%	36.2%	26.2%	16.9%
RMD	10.3%	61.7%	39.5%	27.4%
COO	6.1%	64.4%	20.5%	5.6%
SOLV	-0.6%	53.7%	33.3%	17.3%
ALGN	2.9%	67.7%	22.2%	10.5%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity6.5 B $74%
Current Liabilities1.4 B $15%
Long-term Liabilities946.2 M $11%

Key Figures

YoY change

Total Assets8.8 B $+16.7%

Total Liabilities2.3 B $+14.0%

Total Equity6.5 B $+17.7%

Cash & ST Investments1.7 B $+79.0%

Total Debt847.7 M $+0.9%

Net Debt-821.7 M $—

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
RMD	3.01	13.0%	-0.38	73.9%
WST	2.71	10.6%	-0.24	72.8%
RMD	3.01	13.0%	-0.37	73.9%
COO	1.27	29.9%	2.68	66.0%
SOLV	1.07	102.2%	1.64	35.2%
ALGN	1.39	2.8%	-1.04	65.7%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow1.9 B $+14.9%

Capital Expenditures139.2 M $+57.2%

Free Cash Flow1.8 B $+12.5%

Dividends Paid-341.4 M $-212.4%

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
RMD	34.2%	31.7%	2.5%	124.8%
WST	22.2%	14.2%	8.0%	131.8%
RMD	34.1%	31.6%	2.6%	124.4%
COO	22.5%	13.5%	9.1%	404.2%
SOLV	1.8%	-2.5%	4.3%	10.5%
ALGN	16.9%	16.8%	4.6%	160.9%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.